GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Profound Medical Corp (NAS:PROF) » Definitions » Enterprise Value

Profound Medical (Profound Medical) Enterprise Value : $145.92 Mil (As of May. 28, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Profound Medical Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Profound Medical's Enterprise Value is $145.92 Mil. Profound Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-29.26 Mil. Therefore, Profound Medical's EV-to-EBIT ratio for today is -4.99.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Profound Medical's Enterprise Value is $145.92 Mil. Profound Medical's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $-28.10 Mil. Therefore, Profound Medical's EV-to-EBITDA ratio for today is -5.19.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Profound Medical's Enterprise Value is $145.92 Mil. Profound Medical's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $7.25 Mil. Therefore, Profound Medical's EV-to-Revenue ratio for today is 20.13.


Profound Medical Enterprise Value Historical Data

The historical data trend for Profound Medical's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Profound Medical Enterprise Value Chart

Profound Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 125.96 333.26 167.54 189.09 163.16

Profound Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 161.31 245.61 192.43 163.16 174.43

Competitive Comparison of Profound Medical's Enterprise Value

For the Medical Devices subindustry, Profound Medical's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Profound Medical's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Profound Medical's Enterprise Value falls into.



Profound Medical Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Profound Medical's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Profound Medical's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Profound Medical  (NAS:PROF) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Profound Medical's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=145.917/-29.263
=-4.99

Profound Medical's current Enterprise Value is $145.92 Mil.
Profound Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-29.26 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Profound Medical's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=145.917/-28.095
=-5.19

Profound Medical's current Enterprise Value is $145.92 Mil.
Profound Medical's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-28.10 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Profound Medical's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=145.917/7.249
=20.13

Profound Medical's current Enterprise Value is $145.92 Mil.
Profound Medical's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Profound Medical Enterprise Value Related Terms

Thank you for viewing the detailed overview of Profound Medical's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Profound Medical (Profound Medical) Business Description

Traded in Other Exchanges
Address
2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.